| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Erlotinib Hydrochloride | FAERS: 9 | US FAERS | |
| 2 | Erlotinib Hydrochloride | FAERS: 6 | US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 4 | US FAERS | |
| 4 | Zoledronic Acid | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | olaparib | FAERS: 4 | US FAERS | |
| 6 | Everolimus | FAERS: 3 | US FAERS | |
| 7 | pazopanib | FAERS: 3 | US FAERS | |
| 8 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 9 | Letrozole | FAERS: 2 | US FAERS | |
| 10 | Octreotide | FAERS: 2 | US FAERS | |
| 11 | osimertinib | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | regorafenib | FAERS: 2 | US FAERS | |
| 13 | Alendronate | FAERS: 1 | US FAERS | |
| 14 | CH5424802 | FAERS: 1 | US FAERS | |
| 15 | Capecitabine | FAERS: 1 | US FAERS | |
| 16 | Dexlansoprazole | FAERS: 1 | US FAERS | |
| 17 | Fulvestrant | FAERS: 1 | US FAERS | |
| 18 | MDV 3100 | FAERS: 1 | US FAERS | |
| 19 | Norgestrel | FAERS: 1 | US FAERS | |
| 20 | Pamidronate | FAERS: 1 | US FAERS | |
| 21 | Pamidronate | FAERS: 1 | US FAERS | |
| 22 | Sorafenib | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Thyroxine | FAERS: 1 | US FAERS | |
| 24 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 25 | Vemurafenib | FAERS: 1 | US FAERS | |
| 26 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 27 | ceritinib | FAERS: 1 | US FAERS | |
| 28 | paricalcitol | FAERS: 1 | US FAERS | |
| 29 | pazopanib | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 30 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Tamoxifen | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.